
09 Jan 2023
Cenkos: Venture Life Group Plc -- Commercial development
Venture Life has announced a new license agreement and three new international distribution agreements. The license relates to a new mouth ulcer product developed by the group's Biokosmes division, highlighting the company's innovation and development capabilities. International distribution agreements have been signed for Gelclair and Pomi-T, demonstrating the group's global reach and its ability to maximise the value of acquired brands. We believe these new agreements epitomise Venture Life's ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Venture Life Group Plc -- Commercial development
Venture Life Group Plc (VLG:LON) | 59.5 0 0.0% | Mkt Cap: 76.2m
- Published:
09 Jan 2023 -
Author:
Chris Donnellan -
Pages:
7 -
Venture Life has announced a new license agreement and three new international distribution agreements. The license relates to a new mouth ulcer product developed by the group's Biokosmes division, highlighting the company's innovation and development capabilities. International distribution agreements have been signed for Gelclair and Pomi-T, demonstrating the group's global reach and its ability to maximise the value of acquired brands. We believe these new agreements epitomise Venture Life's ....